Stepped Care for Patients to Optimize Whole Recovery (SC-POWR): An Effectiveness Trial Evaluating a Stepped Care Model for Individuals With Opioid Use Disorder and Chronic Pain
Restricted accessArticle commentaryFirst published online January, 2025
Stepped Care for Patients to Optimize Whole Recovery (SC-POWR): An Effectiveness Trial Evaluating a Stepped Care Model for Individuals With Opioid Use Disorder and Chronic Pain
Many patients who receive treatment for opioid use disorder (OUD) report experiencing chronic pain (CP), which is associated with high levels of ongoing nonmedical opioid use and low retention in OUD treatment. In pilot studies of patients with OUD receiving buprenorphine or methadone who had CP, cognitive behavioral therapy (CBT) attenuated nonmedical opioid use compared with treatment-as-usual (TAU), but patients in both treatment arms exhibited similar pain improvements. Adding exercise and stress reduction to this model may augment pain-related outcomes. With funding from National Institutes of Health, we plan to conduct a randomized clinical trial of 316 patients with OUD and CP to test the effectiveness of TAU compared with Stepped Care for Patients to Optimize Whole Recovery (SC-POWR) to reduce nonmedical opioid use and pain (primary outcomes) (Aim 1) and decrease pain intensity and interference, alcohol use, anxiety, depression and stress, and improve sleep (secondary outcomes) (Aim 2). Eligible participants will be randomized to receive TAU (buprenorphine or methadone and at least once a month individual or group counseling) or SC-POWR (ie, TAU and up to 12 CBT sessions) for 24 weeks. Based on prespecified nonresponse criteria, SC-POWR may be stepped up at week 6 to receive onsite weekly group sessions of exercise (Wii Fit, Tai Chi) and “stepped up” again at week 15 to receive weekly group sessions of stress reduction (relaxation training, auricular acupuncture). They will be followed for another 24 weeks to evaluate durability of treatment response for illicit opioid use, alcohol use, pain, anxiety, depression, stress, sleep, and retention in medications for OUD (Aim 3).
RosenblumAJosephHFongCKipnisSClelandCPortenoyRK.Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA. 2003;289(18):2370-2378.
2.
JamisonRNKauffmanJKatzNP.Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manage. 2000;19(1):53-62.
3.
DahlhamerJLucasJZelayaC, et al. Prevalence of chronic pain and high-impact chronic pain among adults—United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(36):1001-1006.
4.
PelesESchreiberSGordonJAdelsonM.Significantly higher methadone dose for methadone maintenance treatment (MMT) patients with chronic pain. Pain. 2005;113(3):340-346.
5.
DunnKEFinanPHTompkinsDAFingerhoodMStrainEC.Characterizing pain and associated coping strategies in methadone and buprenorphine-maintained patients. Drug Alcohol Depend. 2015;157:143-149.
6.
WachholtzAFosterSCheatleM.Psychophysiology of pain and opioid use: implications for managing pain in patients with an opioid use disorder. Drug Alcohol Depend. 2015;146:1-6.
7.
RowbothamMCWallaceM.Evolution of Analgesic Tolerance and Opioid-Induced Hyperalgesia over 6 months: double-blind randomized trial incorporating experimental pain models. J Pain. 2020;21:1031-1046. doi:10.1016/j.jpain.2020.01.005
8.
ComptonPAWasserTECheatleMD.Increased experimental pain sensitivity in chronic pain patients who developed opioid use disorder. Clin J Pain. 2020;36:667-674.
9.
HigginsCSmithBMatthewsK.Evidence of opioid-induced hyperalgesia in clinical populations after chronic opioid exposure: a systematic review and meta-analysis. Br J Anaesth. 2019;122(6):e114-e126.
10.
BeitelMSavantJDCutterCJPetersSBelisleNBarryDT.Psychopathology and pain correlates of dispositional optimism in methadone-maintained patients. Am J Addict. 2012;21:S56-S62.
11.
DhingraLMassonCPerlmanDC, et al. Epidemiology of pain among outpatients in methadone maintenance treatment programs. Drug Alcohol Depend. 2013;128:161-165.
12.
PotterJSChakrabartiADomierCPHillhouseMPWeissRDLingW.Pain and continued opioid use in individuals receiving buprenorphine-naloxone for opioid detoxification: secondary analyses from the Clinical Trials Network. J Subst Abuse Treat. 2010;38(Suppl. 1):S80-S86.
13.
SteinMDHermanDSBaileyGL, et al. Chronic pain and depression among primary care patients treated with buprenorphine. J Gen Intern Med. 2015;30:935-941.
14.
HigginsCSmithBHMatthewsK.Substance misuse in patients who have comorbid chronic pain in a clinical population receiving methadone maintenance therapy for the treatment of opioid dependence. Drug Alcohol Depend. 2018;193:131-136.
15.
HigginsCSmithBHMatthewsK.Comparison of psychiatric comorbidity in treatment-seeking, opioid-dependent patients with versus without chronic pain. Addiction. 2020;115(2):249-258.
16.
EllisMSKasperZCiceroT.Assessment of chronic pain management in the treatment of opioid use disorder: gaps in care and implications for treatment outcomes. J Pain2012; 22(4):432-439. doi:10.1016/j.jpain.2020.10.005
17.
JohnWSWuL-T.Chronic non-cancer pain among adults with substance use disorders: prevalence, characteristics, and association with opioid overdose and healthcare utilization. Drug Alcohol Depend. 2020;209:107902.
18.
PelesESchreiberSAdelsonM.Documented poor sleep among methadone-maintained patients is associated with chronic pain and benzodiazepine abuse, but not with methadone dose. Eur Neuropsychopharmacol. 2009;19(8):581-588.
19.
TsuiJILiraMCChengDM, et al. Chronic pain, craving, and illicit opioid use among patients receiving opioid agonist therapy. Drug Alcohol Depend. 2016;166:26-31.
20.
MacLeanRRSpinolaSManhapraASofuogluM.Systematic review of pain severity and opioid craving in chronic pain and opioid use disorder. Pain Med. 2020;21(2):e146-e163.
21.
MessinaBGWorleyMJ.Effects of craving on opioid use are attenuated after pain coping counseling in adults with chronic pain and prescription opioid addiction. J Consult Clin Psychol. 2019;87(10):918-926.
22.
AshrafiounL.Prescription opioid craving: relationship with pain and substance use-related characteristics. Subst Use Misuse. 2016;51(11):1512-1520.
23.
GriffinMLMcDermottKAMcHughRKFitzmauriceGMJamisonRNWeissRD.Longitudinal association between pain severity and subsequent opioid use in prescription opioid dependent patients with chronic pain. Drug Alcohol Depend. 2016;163:216-221.
24.
McDermottKAGriffinMLMcHughRK, et al. Long-term naturalistic follow-up of chronic pain in adults with prescription opioid use disorder. Drug Alcohol Depend. 2019;205:107675.
25.
WorleyMJHeinzerlingKGShoptawSLingW.Volatility and change in chronic pain severity predict outcomes of treatment for prescription opioid addiction. Addiction. 2017;112(7):1202-1209.
26.
DahlmanDKralAHWengerLHakanssonANovakSP.Physical pain is common and associated with nonmedical prescription opioid use among people who inject drugs. Subst Abuse Treat Prev Policy. 2017;12(1):1-11.
National Academies of Sciences Engineering and Medicine. Medications for Opioid Use Disorder Save Lives. The National Academies Press. 2019.
29.
Center for Substance Abuse Treatment. Substance Abuse Treatment for Persons with Co-occurring Disorders. Treatment Improvement Protocol (TIP) Series 42, DHHS Publication No. (SMA) 05-3922. Substance Abuse and Mental Health Services Administration, 2005.
30.
SpringerSAKorthuisPTdel RioC.Integrating treatment at the intersection of opioid use disorder and infectious disease epidemics in medical settings: a call for action after a National Academies of Sciences, Engineering, and Medicine workshop. Ann Intern Med. 2018;169(5):335-336.
31.
Substance Abuse and Mental Health Services Administration. National Survey of Substance Abuse Treatment Services (N-SSATS). 2020. Data on Substance Abuse Treatment Facilities. Substance Abuse and Mental Health Services Administration, 2021.
32.
BarryDTBernardMJBeitelMMooreBAKernsRDSchottenfeldRS.Counselors’ experiences treating methadone-maintained patients with chronic pain: a needs assessment study. J Addict Med. 2008;2(2):108-111.
33.
BeitelMOberleitnerLKahnM, et al. Drug counselor responses to patients’ pain reports: a qualitative investigation of barriers and facilitators to treating patients with chronic pain in methadone maintenance treatment. Pain Med. 2017;18:2152-2161.
34.
OberleitnerLBeitelMSchottenfeldRS, et al. Drug counselors’ attitudes toward non-pharmacologic treatments for chronic pain. J Addict Med. 2016;10:34-39.
35.
ButnerJLBoneCPonce MartinezCC, et al. Training drug counselors to deliver a brief psychoeducational intervention for chronic pain among patients in opioid agonist treatment: a pilot investigation. Subst Abus. 2018;39:199-205.
36.
CarrollKMNuroKF.One size cannot fit all: a stage model for psychotherapy manual development. Clin Psychol (New York). 2002;9(4):396-406.
37.
Von KorffMTiemensB. Individualized stepped care of chronic illness. West J Med. 2000;172(2):133-137.
38.
GarciaANCookCERhonDI.Adherence to stepped care for management of musculoskeletal knee pain leads to lower health care utilization, costs, and recurrence. Am J Med. 2021;134(3):351-360.e1.
39.
SpeedTJParekhVCoeWDenisA.Comborbid chronic pain and opioid use disorder: literature review and potential treatment innovations. Int Rev Psychiatry2018;30(5):136-146. doi:10.1080/09540261.2018.1514369
40.
SobellMBSobellLC.Stepped care as a heuristic approach to the treatment of alcohol problems. J Consult Clin Psychol. 2000;68(4):573-579.
41.
Substance Abuse and Mental Health Services Administration. Medications for Opioid Use Disorder. Treatment Improvement Protocol (TIP) Series 63, Publication No. PEP20-02-01-005. Substance Abuse and Mental Health Services Administration;2020.
42.
RosenbergerPHPhilipEJLeeAKernsRD.The VHA’s National Pain Management Strategy: implementing the stepped care model. Fed Pract. 2011;28(8):39-42.
43.
GordonAJDrexlerKHawkinsEJ, et al. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities. Subst Abus. 2020;41(3):275-282.
44.
FritzJMRhonDITeyhenDS, et al. A Sequential Multiple-Assignment Randomized Trial (SMART) for stepped care management of low back pain in the military health system: a trial protocol. Pain Med. 2020;21(Supplement_2):S73-S82.
45.
BairMJOutcaltSDAngDWuJYuZ.Pain and psychological outcomes among Iraq and Afghanistan veterans with chronic pain and PTSD: ESCAPE Trial longitudinal results. Pain Med. 2020;21(7):1369-1376.
46.
Von KorffMDeBarLLKrebsEEKernsRDDeyoRAKeefeFJ.Graded chronic pain scale revised: mild, bothersome, and high-impact chronic pain. Pain. 2020;161(3):651-661.
47.
American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders. 5th ed.American Psychiatric Association; 2013.
48.
BroglioK.Randomization in clinical trials: permuted blocks and stratification. JAMA. 2018;319(21):2223-2224.
49.
MaddenLMFarnumSOEggertKF, et al. An investigation of an open-access model for scaling up methadone maintenance treatment. Addiction. 2018;113:1450-1458.
50.
KrebsEELorenzKABairMJ, et al. Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference. J Gen Intern Med. 2009;24:733-738.
51.
CarrollKMNichCBallSAMcCanceEFrankforterTLRounsavilleBJ.One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatment. Addiction. 2000;95(9):1335-1349.
52.
GaetaMBeitelMCutterCBarryD.Cognitive-behavioral therapy for opioid use disorder and chronic pain. In: RajendramRPatelVPreedyVRMartinC.The Neuroscience of Anesthetics and Analgesics. Elsevier Inc; 2022; 235-246.
53.
SearleASpinkMHoAChuterV.Exercise interventions for the treatment of chronic low back pain: a systematic review and meta-analysis of randomised controlled trials. Clin Rehabil. 2015;29(12):1155-1167.
54.
ChouRDeyoRFriedlyJ, et al. Nonpharmacologic therapies for low back pain: A systematic review for an american college of physicians clinical practice guideline. Ann Intern Med. 2017;166(7):493-505.
55.
MorresIDHatzigeorgiadisAStathiA, et al. Aerobic exercise for adult patients with major depressive disorder in mental health services: A systematic review and meta-analysis. Depress Anxiety. 2019;36(1):39-53.
56.
KliglerBBairMJBanerjeaR, et al. Clinical policy recommendations from the VHA state-of-the-art conference on non-pharmacological approaches to chronic musculoskeletal pain. J Gen Intern Med. 2018;33(1):16-23.
57.
QaseemAWiltTJMcLeanRMForcieaM; for the Clinical Guidelines Committee of the American College of Physicians. Noninvasive treatments for acute, subacute, and chronic low back pain: A clinical practice guideline from the american college of physicians. Ann Intern Med. 2017;166(7):514-530.
58.
O’ConnorSRTullyMARyanB, et al. Walking exercise for chronic musculoskeletal pain: systematic review and meta-analysis. Arch Phys Med Rehabil. 2015;96(4):724-734.e723.
59.
HallAMMaherCGLamPFerreiraMLatimerJ.Tai chi exercise for treatment of pain and disability in people with persistent low back pain: a randomized controlled trial. Arthritis Care Res. 2011;63(11):1576-1583.
60.
WeifenWMuheremuAChaohuiCMDLWLeiS.Effectiveness of tai chi practice for non-specific chronic low back pain on retired athletes: a randomized controlled study. J musculoskeletal Pain. 2013;21(1):37-45.
61.
QinJZhangYWuL, et al. Effect of Tai Chi alone or as additional therapy on low back pain: Systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2019;98(37):e17099. doi:17010.11097/MD.0000000000017099
62.
ZhangYLoprinziPDYangLLiuJLiuSZouL.The beneficial effects of traditional Chinese exercises for adults with low back pain: a meta-analysis of randomized controlled trials. Medicina (Kaunas). 2019;55(5):118. doi:110.3390/medicina55050118
63.
OwenPJMillerCTMundellNL, et al. Which specific modes of exercise training are most effective for treating low back pain? Network meta-analysis. Br J Sports Med. 2020;54(21):1279-1287.
64.
SullivanABSchemanJVenesyDDavinS.The role of exercise and types of exercise in the rehabilitation of chronic pain: specific or nonspecific benefits. Curr Pain Headache Rep. 2012;16(2):153-161.
65.
BarryDTSavantJDBeitelM, et al. The feasibility and acceptability of groups for pain management in methadone maintenance treatment. J Addict Med. 2014;8(5):338-344.
66.
DiMeolaKAHaynesJBaroneM, et al. A pilot investigation of nonpharmacological pain management intervention groups in methadone maintenance treatment. J Addict Med. 2022;16(2):229-234.
67.
DimeolaKHaynesJBaroneM, et al. A pilot investigation of nonpharmacological pain management intervention groups in methadone maintenance treatment. J Addict Med. 2022;16(2):229-234.
68.
MooersMBeitelMBarryDT.The feasibility of providing Tai Chi and Wii Fit groups in an opioid treatment program. Manuscript in Preparation.
69.
HarrisPATaylorRThielkeR, et al. Conde, Research electronic data capture (REDCap) – A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381.
70.
HarrisPATaylorRMinorBL, et al. The REDCap consortium: Building an international community of software partners. J Biomed Inform. 2019; 103208. doi: 10.1016/j.jbi.2019.103208
71.
SobellLSobellM.Timeline Followback User’s Guide: A Calendar Method for Assessing Alcohol and Drug Use. Addiction Research Foundation; 1996.
72.
KeanJMonahanPOKroenkeK, et al. Comparative responsiveness of the PROMIS pain interference short forms, brief pain inventory, PEG, and SF-36 bodily pain subscale. Med Care. 2016;54(4):414-421.
73.
DworkinRHTurkDCFarrarJT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113(1-2):9-19.
74.
CleelandCSRyanKM.Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap. 1994;23(2):129-138.
75.
KroenkeKSpitzerRLWilliamsJBMonahanPOLöweB.Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317-325.
76.
LöweBKroenkeKGräfeK.Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res. 2005;58(2):163-171.
77.
CohenSKamarckTMermelsteinR.A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385-396.
78.
PanzaGAWeinstockJAshGIPescatelloLS.Psychometric evaluation of the Timeline Followback for Exercise among college students. Psychol Sport Exercise. 2012;13(6):779-788.
79.
BrownRAAbrantesAMMinamiH, et al. A preliminary, randomized trial of aerobic exercise for alcohol dependence. J Subst Abuse Treat. 2014;47(1):1-9.
80.
LuszczynskaAScholzUSchwarzerR.The general self-efficacy scale: multicultural validation studies. J Psychol. 2005;139(5):439-457.
81.
SullivanMJBishopSRPivikJ.The pain catastrophizing scale: development and validation. Psychol Assess. 1995;7(4):524.
82.
WobySRRoachNKUrmstonMWatsonPJ.Psychometric properties of the TSK-11: a shortened version of the Tampa Scale for Kinesiophobia. Pain. 2005;117(1-2):137-144.
83.
TkachukGAHarrisCA.Psychometric properties of the Tampa Scale for Kinesiophobia-11 (TSK-11). J Pain. 2012;13(10):970-977.
84.
AttkissonCCGreenfieldTK.The UCSF Client Satisfaction Scales: I. The Client Satisfaction Questionnaire-8. In: MaruishME.The Use of Psychological Testing for Treatment Planning and Outcomes Assessment: Instruments for Adults. Lawrence Erlbaum Associates Publishers; 2004; 799-811.
85.
ThomasMAAltermanAICacciolaJMetzgerDO’brienCP.A new measure of substance abuse treatment initial studies of the treatment services review. J Nerv Ment Dis. 1992;180(2):101-110.
86.
StevanovicD.Quality of Life Enjoyment and Satisfaction Questionnaire–short form for quality of life assessments in clinical practice: a psychometric study. J Psychiatr Ment Health Nurs. 2011;18(8):744-750.
87.
SmithLRMittalMLWagnerKCopenhaverMMCunninghamCOEarnshawVA.Factor structure, internal reliability and construct validity of the Methadone Maintenance Treatment Stigma Mechanisms Scale (MMT-SMS). Addiction. 2020;115(2):354-367.
88.
ScottWYuLPatelSMcCrackenLM.Measuring stigma in chronic pain: preliminary investigation of instrument psychometrics, correlates, and magnitude of change in a prospective cohort attending interdisciplinary treatment. J Pain. 2019;20(10):1164-1175.
89.
VilsaintCLKellyJFBergmanBGGroshkovaTBestDWhiteW.Development and validation of a Brief Assessment of Recovery Capital (BARC-10) for alcohol and drug use disorder. Drug Alcohol Depend. 2017;177:71-76.
